India markets closed

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.12+0.18 (+1.51%)
As of 1:30PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2021)Next qtr. (Sep 2021)Current year (2021)Next year (2022)
No. of analysts6677
Avg. Estimate-0.53-0.37-1.7-0.8
Low estimate-0.72-0.69-2.54-2.59
High estimate-0.31-0.08-1.010.69
Year ago EPS-0.54-0.350.18-1.7
Revenue estimateCurrent qtr. (Jun 2021)Next qtr. (Sep 2021)Current year (2021)Next year (2022)
No. of analysts6677
Avg. Estimate2.36M12.64M29.6M96.99M
Low estimateN/AN/A16.04M4.91M
High estimate10.15M30M45.4M151.8M
Year ago sales5.63M9.27M135.08M29.6M
Sales growth (year/est)-58.10%36.40%-78.10%227.70%
Earnings history29/6/202029/9/202030/12/202030/3/2021
Est. EPS-0.67-0.60.36-0.59
Actual EPS-0.54-0.351.59-0.47
Difference0.130.251.230.12
Surprise %19.40%41.70%341.70%20.30%
EPS trendCurrent qtr. (Jun 2021)Next qtr. (Sep 2021)Current year (2021)Next year (2022)
Current estimate-0.53-0.37-1.7-0.8
7 days ago-0.53-0.37-1.7-0.8
30 days ago-0.53-0.37-1.7-0.8
60 days ago-0.53-0.37-1.7-0.8
90 days ago-0.61-0.41-1.92-0.77
EPS revisionsCurrent qtr. (Jun 2021)Next qtr. (Sep 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCARAIndustrySector(s)S&P 500
Current qtr.1.90%N/AN/AN/A
Next qtr.-5.70%N/AN/AN/A
Current year-1,044.40%N/AN/AN/A
Next year52.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A